APA (7th ed.) Citation

MS, T., BR, L., JM, P., EA, D., RH, B., MJ, C., . . . LD, N. (2023). Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: A 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet (London, England), 402(10396), 129. https://doi.org/10.1016/S0140-6736(23)00731-6

Chicago Style (17th ed.) Citation

MS, Thakar, et al. "Measuring the Effect of Newborn Screening on Survival After Haematopoietic Cell Transplantation for Severe Combined Immunodeficiency: A 36-year Longitudinal Study from the Primary Immune Deficiency Treatment Consortium." Lancet (London, England) 402, no. 10396 (2023): 129. https://doi.org/10.1016/S0140-6736(23)00731-6.

MLA (9th ed.) Citation

MS, Thakar, et al. "Measuring the Effect of Newborn Screening on Survival After Haematopoietic Cell Transplantation for Severe Combined Immunodeficiency: A 36-year Longitudinal Study from the Primary Immune Deficiency Treatment Consortium." Lancet (London, England), vol. 402, no. 10396, 2023, p. 129, https://doi.org/10.1016/S0140-6736(23)00731-6.